87 related articles for article (PubMed ID: 22082483)
1. HCV infection by cell-to-cell transmission: choice or necessity?
Carloni G; Crema A; Valli MB; Ponzetto A; Clementi M
Curr Mol Med; 2012 Jan; 12(1):83-95. PubMed ID: 22082483
[TBL] [Abstract][Full Text] [Related]
2. Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets.
Crema A; Ponzetto A; Clementi M; Carloni G
Curr Drug Targets; 2015; 16(7):757-70. PubMed ID: 25694122
[TBL] [Abstract][Full Text] [Related]
3. A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.
Harman C; Zhong L; Ma L; Liu P; Deng L; Zhao Z; Yan H; Struble E; Virata-Theimer ML; Zhang P
J Virol; 2015 Jan; 89(1):492-501. PubMed ID: 25339761
[TBL] [Abstract][Full Text] [Related]
4. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
[TBL] [Abstract][Full Text] [Related]
5. Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
Fan H; Qiao L; Kang KD; Fan J; Wei W; Luo G
J Virol; 2017 Jul; 91(13):. PubMed ID: 28404852
[TBL] [Abstract][Full Text] [Related]
6. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
Bose M; Mullick R; Das S; Das S; Karande AA
Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
Perrault M; Pécheur EI
Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
[TBL] [Abstract][Full Text] [Related]
8. CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
Grigorov B; Molle J; Rubinstein E; Zoulim F; Bartosch B
J Gen Virol; 2017 Jul; 98(7):1646-1657. PubMed ID: 28721844
[TBL] [Abstract][Full Text] [Related]
9. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.
Deest M; Westhaus S; Steinmann E; Manns MP; von Hahn T; Ciesek S
Antiviral Res; 2014 Jan; 101():37-44. PubMed ID: 24211330
[TBL] [Abstract][Full Text] [Related]
10. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
11. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
[TBL] [Abstract][Full Text] [Related]
12. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
[TBL] [Abstract][Full Text] [Related]
13. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
Ramanathan A; Gusarova V; Stahl N; Gurnett-Bander A; Kyratsous CA
PLoS One; 2016; 11(4):e0154498. PubMed ID: 27115873
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus entry and neutralization.
Stamataki Z; Grove J; Balfe P; McKeating JA
Clin Liver Dis; 2008 Aug; 12(3):693-712, x. PubMed ID: 18625435
[TBL] [Abstract][Full Text] [Related]
17. Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.
Benedicto I; Molina-Jiménez F; Moreno-Otero R; López-Cabrera M; Majano PL
World J Gastroenterol; 2011 Jun; 17(22):2683-90. PubMed ID: 21734774
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization.
Falkowska E; Kajumo F; Garcia E; Reinus J; Dragic T
J Virol; 2007 Aug; 81(15):8072-9. PubMed ID: 17507469
[TBL] [Abstract][Full Text] [Related]
19. HCV Interplay with Lipoproteins: Inside or Outside the Cells?
Cosset FL; Mialon C; Boson B; Granier C; Denolly S
Viruses; 2020 Apr; 12(4):. PubMed ID: 32290553
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus entry: role of host and viral factors.
Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]